Risk in Securing, Training and Retaining Specialized Personnel
First written in FY2016. 15 of 18 entries say "Restated". Latest entry: FY2026.
The whole theme swung hardest in 2026: 34 of 109 companies on the "Worse" side.
5 other companies' latest entry also says "Other".
- FY2026Broadening the Range of Required PersonnelAnnual report
「In addition, it is necessary to optimise the allocation of a broad range of personnel in response to business diversification and expansion, including personnel in marketing, domestic and overseas sales, international operations, M&A execution and internal control.」
In addition to the existing risks relating to securing, training and retaining specialised personnel, personnel allocation for medical DX, overseas expansion, M&A execution and internal control was explicitly identified as a risk issue. - FY2025Shift in focus to optimising personnel allocationAnnual report
「The Group plans to optimise personnel allocation in order to establish an efficient operating structure. However, if the optimisation of personnel allocation does not proceed as planned, the Group's business and operations may be disrupted.」
In addition to the existing need to secure, train and retain specialised personnel, optimising personnel allocation in connection with the restructuring of the business portfolio was explicitly identified as a key issue. - FY2024-Q2RestatedAnnual report
「During the six-month period ended [the current second quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
It is stated that there have been no material changes in the risk of securing, training and retaining specialised personnel. - FY2024-Q1RestatedAnnual report
「During the three-month period ended [the current first quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
It is stated that there have been no material changes in the risk of securing, training and retaining specialised personnel. - FY2023RestatedAnnual report
「However, if the securing of personnel and the training of in-house personnel do not proceed as planned, the Group's business and operations may be disrupted.」
The risks relating to securing, training and retaining specialised personnel in medicine and pharmaceuticals, marketing, sales, international operations and internal control, among other areas, continue to be disclosed. - FY2023-Q3RestatedAnnual report
「During the nine-month period ended [the current third quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
It is stated that there have been no material changes in the risk of securing, training and retaining specialised personnel. - FY2023-Q2RestatedAnnual report
「During the six-month period ended [the current second quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
It is stated that there have been no material changes in the risk of securing, training and retaining specialised personnel. - FY2022-Q1RestatedAnnual report
「During the three-month period ended [the current first quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
It is stated that there have been no material changes in the risk of securing, training and retaining specialised personnel. - FY2021-Q3RestatedAnnual report
「During the nine-month period ended [the current third quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
It is stated that there have been no material changes in the risk of securing, training and retaining specialised personnel. - FY2021-Q1RestatedAnnual report
「During the three-month period ended [the current first quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
It is stated that there have been no material changes in the risk of securing, training and retaining specialised personnel. - FY2020RestatedAnnual report
「However, if the securing of personnel and the training of in-house personnel do not proceed as planned, the Group's business and operations may be disrupted.」
The risks relating to securing, training and retaining specialised personnel in medicine and pharmaceuticals, marketing, sales, international operations and internal control, among other areas, continue to be disclosed. - FY2020-Q2RestatedAnnual report
「During the six-month period ended [the current second quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
It is stated that there have been no material changes in the risk of securing, training and retaining specialised personnel. - FY2020-Q1RestatedAnnual report
「During the three-month period ended [the current first quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
It is stated that there have been no material changes in the risk of securing, training and retaining specialised personnel. - FY2019-Q3RestatedAnnual report
「During the nine-month period ended [the current third quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
The risk of securing, training and retaining specialised personnel is disclosed in a consolidated statement as having undergone no material changes. - FY2019-Q2RestatedAnnual report
「During the six-month period ended [the current second quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
The risk of securing, training and retaining specialised personnel is disclosed in a consolidated statement as having undergone no material changes. - FY2019-Q1RestatedAnnual report
「During the three-month period ended [the current first quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
The risk of securing, training and retaining specialised personnel is disclosed in a consolidated statement as having undergone no material changes. - FY2018RestatedAnnual report
「However, if the securing of personnel and the training of in-house personnel do not proceed as planned, the Group's business and operations may be disrupted.」
The risks relating to securing, training and retaining specialised personnel, as well as personnel in marketing, sales, international operations and internal control, continue to be disclosed. - FY2016First statedAnnual report
「However, if the securing of personnel and the training of in-house personnel do not proceed as planned, the Group's business and operations may be disrupted.」
In addition to specialists in medicine and pharmaceuticals, the Group needs to secure personnel in marketing, sales and internal control.